Amengual Olga, Atsumi Tatsuya, Koike Takao
Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Clin Immunol. 2004 Aug;112(2):144-9. doi: 10.1016/j.clim.2004.02.013.
The preliminary classification criteria for definite antiphospholipid syndrome (APS) include the presence of anticardiolipin antibodies (aCL) and/or lupus anticoagulant (LA) as laboratory criteria. However, antiphospholipid antibodies (aPL) are a heterogeneous group of antibodies comprising also antibodies against phospholipid-binding proteins or their complexes with phospholipids. Prothrombin is one of the antigen recognized by aPL. In the last decade, there has been increasing interest in antibodies against prothrombin alone and those against phosphatidylserine-prothrombin complex. The latter, phosphatidylserine-dependent antiprothrombin antibodies (aPT), have been closely associated with APS and LA. In this paper, we review the properties of antiprothrombin antibodies.
确诊抗磷脂综合征(APS)的初步分类标准包括抗心磷脂抗体(aCL)和/或狼疮抗凝物(LA)的存在作为实验室标准。然而,抗磷脂抗体(aPL)是一组异质性抗体,还包括针对磷脂结合蛋白或其与磷脂复合物的抗体。凝血酶原是aPL识别的抗原之一。在过去十年中,人们对单独的抗凝血酶原抗体以及针对磷脂酰丝氨酸-凝血酶原复合物的抗体越来越感兴趣。后者,即磷脂酰丝氨酸依赖性抗凝血酶原抗体(aPT),与APS和LA密切相关。在本文中,我们综述抗凝血酶原抗体的特性。